These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 3274273)
1. Evidence for an accelerated rejection response to cardiac allografts in antigen-treated mice which then resolves. Superina RA; Wood KJ; Millard P; Morris PJ Transplant Proc; 1987 Feb; 19(1 Pt 2):1056-7. PubMed ID: 3274273 [No Abstract] [Full Text] [Related]
2. Biologic modification of the immune response in mouse cardiac isografts using gene transfer. Fyfe AI; Ardehali A; Laks H; Drinkwater DC; Lusis AJ J Heart Lung Transplant; 1995; 14(6 Pt 2):S165-70. PubMed ID: 8719479 [No Abstract] [Full Text] [Related]
3. Immunosuppression to cardiac allografts and soluble antigens by anti-vascular cellular adhesion molecule-1 and anti-very late antigen-4 monoclonal antibodies. Isobe M; Suzuki J; Yagita H; Okumura K; Yamazaki S; Nagai R; Yazaki Y; Sekiguchi M J Immunol; 1994 Dec; 153(12):5810-8. PubMed ID: 7527450 [TBL] [Abstract][Full Text] [Related]
4. Survival of MHC deficient mouse heterotopic cardiac allografts and xenografts. Campos L; Deli BC; Kern JH; Kim JI; Naji A; Barker CF; Markmann JF Transplant Proc; 1995 Feb; 27(1):254-5. PubMed ID: 7878991 [No Abstract] [Full Text] [Related]
5. Induction of transplantation tolerance by treatment with ICAM-1 antisense oligonucleotides and anti-LFA-1 monoclonal antibodies. Stepkowski SM; Tu Y; Condon TP; Bennett CF Transplant Proc; 1995 Feb; 27(1):113. PubMed ID: 7878822 [No Abstract] [Full Text] [Related]
6. Importance of the presence of antigen for induction of transplantation tolerance. Olausson M; Mjörnstedt L; Wramner L; Söderström T; Brynger H Transplant Proc; 1987 Feb; 19(1 Pt 1):454-6. PubMed ID: 3274804 [No Abstract] [Full Text] [Related]
7. Marked prolongation of incompatible class I deficient heart allografts: paradoxical effects between primarily and secondarily vascularized allografts. Henretta J; Araneda D; Pittman K; Thomas F Transplant Proc; 1995 Feb; 27(1):1303-4. PubMed ID: 7878892 [TBL] [Abstract][Full Text] [Related]
8. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells. Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791 [TBL] [Abstract][Full Text] [Related]
9. Intrathymic alloantigen-mediated, tolerant, completely major histocompatibility complex-mismatched mouse hearts are specifically rejected by adoptively transferred anti-class I L(d+)-specific 2C cells. Otomo N; Motoyama K; Yu S; Shimizu Y; Margenthaler J; Tu F; Flye MW Surgery; 2000 Aug; 128(2):206-12. PubMed ID: 10922993 [TBL] [Abstract][Full Text] [Related]
10. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [TBL] [Abstract][Full Text] [Related]
11. Role of PECAM-1 in acute rejection of fully major histocompatibility complex class II-mismatched cardiac allografts in mice. Schramm R; Menger MD; Schmits R; Harder Y; Kirsch S; Meier C; Schäfers HJ Transplantation; 2007 Aug; 84(4):555-8. PubMed ID: 17713444 [TBL] [Abstract][Full Text] [Related]
12. Neonatally induced transplantation tolerance to primarily vascularised cardiac allografts is not donor-specific. West LJ; Morris PJ; Wood KJ Transplant Proc; 1995 Feb; 27(1):184-5. PubMed ID: 7878966 [No Abstract] [Full Text] [Related]
13. Donor-type single MHC locus products combined with anti-CD4 MAb can induce tolerance to cardiac allografts which is dependent on active suppression. Saitovitch D; Morris PJ; Wood KJ Transplant Proc; 1995 Feb; 27(1):119-20. PubMed ID: 7878844 [No Abstract] [Full Text] [Related]
14. Interleukin-22 deficiency accelerates the rejection of full major histocompatibility complex-disparate heart allografts. Kapessidou P; Poulin L; Dumoutier L; Goldman M; Renauld JC; Braun MY Transplant Proc; 2008 Jun; 40(5):1593-7. PubMed ID: 18589157 [TBL] [Abstract][Full Text] [Related]
16. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells. Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913 [TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide attenuated the rejection of major histocompatibility complex fully-mismatched cardiac allografts in mice. Yan S; Zhang QY; Zhou B; Xue L; Chen H; Wang Y; Zheng SS Transplant Proc; 2009 Jun; 41(5):1855-8. PubMed ID: 19545743 [TBL] [Abstract][Full Text] [Related]
18. Role of selectin-dependent adhesion in cardiac allograft rejection. Yamazaki S; Isobe M; Suzuki J; Tojo S; Horie S; Okubo Y; Sekiguchi M J Heart Lung Transplant; 1998 Oct; 17(10):1007-16. PubMed ID: 9811410 [TBL] [Abstract][Full Text] [Related]
19. Role of ICAM-1 and LFA-1 in a cardiac xenograft rejection model. Miwa S; Kawasaki S; Makuuchi M; Miyasaka M; Yamazaki S; Sekiguchi M; Isobe M Transplant Proc; 1995 Feb; 27(1):111-2. PubMed ID: 7878820 [No Abstract] [Full Text] [Related]
20. Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Yamaura K; Ito K; Tsukioka K; Wada Y; Makiuchi A; Sakaguchi M; Akashima T; Fujimori M; Sawa Y; Morishita R; Matsumoto K; Nakamura T; Suzuki J; Amano J; Isobe M Circulation; 2004 Sep; 110(12):1650-7. PubMed ID: 15364799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]